CClinicalTrials.gg
CompletedNCT06353308Updated Apr 9, 2024

Effectiveness of an Online Intervention Using a Feminist Approach on Gender Equality Promotion and Sexual Violence Prevention in China

An interventional study of Sexual Violence Prevention and Sexual health intervention in Sexual Violence, sponsored by The University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 18 Years to 29 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-09.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled May 2023, registered Mar 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
422
Allocation
Randomized
Ages
18 Years to 29 Years
Sex
All
01

Study summary

This paper presents the findings of a clustered randomized controlled trial (cRCT) that evaluated the effectiveness of an online feminist sexual health intervention among Chinese young adults, providing insights into the impacts of this innovative approach and contribute to the growing body of literature on feminist interventions for sexual health and equality promotion.

02

Conditions studied

  • Sexual Violence
03

In context

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 29 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Young adults aged between 18-29 years old who possessed a mobile phone
  2. Had prior experience in using social media
  3. Were able to read and understand Chinese

Exclusion criteria

Exclusion Criteria:

  1. Those with a physical impediment (e.g., blindness) preventing them from accessing the mobile content
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
422 participants (actual)

Study arms

  • Placebo comparator
    General Sexual Health intervention

    Participants will receive their general online sexual health education programming.

    Behavioral: Sexual health intervention

  • Experimental
    Feminist Sexual Health Intervention

    Participants will receive online feminist sexual health program.

    Behavioral: Sexual Violence Prevention

Interventions

  • BehavioralSexual Violence Prevention

    The intervention included a game, five short videos, two posters, and five online quizzes, which were provided with a frequency of two posts per week and a final real-time online workshop. Materials included content on the spectrum of gender and sexual identities and orientations, gender and sexual roles, consent and communication, body positivity and self-acceptance, sexual pleasure and desire, as well as risky sexual behavior associated with dating app use and the legal issues and risks of sexual assault, such as precautionary steps and available resources.

  • BehavioralSexual health intervention

    This general online sexual health education consisted of online videos, quizzes and game that covered a wide range of diverse topics on love, sex and relationships such as healthy and respectful relationships, body self-esteem, sexual identity and orientation, sexual rights and decision making, in addition to the conventional focus on sexual dysfunction and disease aversion.

06

What researchers measure

Primary outcomes

  1. Rape myth acceptance

    Illinois Rape Myth Acceptance Scale -Short Form, which consists of 17 items (1=not at all agree, 7=very much agree) assessing respondents' belief in rape myths (e.g., "Rape happens when a man's sex drive gets out of control"). The scores range from 17 to 119, with lower scores indicating less subscription to rape myths.

    Time frame: From enrollment to the end of treatment at one week and three months

Secondary outcomes

  1. Sociocultural Attitudes toward Appearance

    Sociocultural Attitudes toward Appearance Questionnaire-3 consisted of eight items assessing the degree to which an individual accepts and internalizes societal standards of beauty. Examples include "I tend to compare my body to people in magazines and on TV" and "Women who appear in TV shows and movies project the type of appearance that I see as my goal." Each item is rated on a five-point Likert scale. The scores range from 8 to 40, with lower scores indicating less endorsement of sociocultural beauty standards.

    Time frame: From enrollment to the end of treatment at one week and three months

  2. Sexual Attitudes Scale

    Sexual Attitudes Scale is a 22-item scale that includes: Permissiveness (six items); Responsibility (four items); Pleasure (four items); Instrumentality (four items); and Communion (four items). The factor items were rated on a five-point Likert-type scale ranging from 1 (strongly agree) to 5 (strongly disagree). After reverse-coding the negatively worded items, the item scores of each factor are summarized to obtain a total score for the factor. High scores indicated a high level of acceptance of the factor. The scores range from 22 to 110.

    Time frame: From enrollment to the end of treatment at one week and three months

  3. Sexual Desire Inventory

    Sexual Desire Inventory is a self-reported scale developed to assess sexual desire. It has 14 items in two aspects: Dyadic Sexual Desire (DSD)and Solitary Sexual Desire (SSD). Items1,2,10 and14 are rated on 8-point scales with responses from 0 (Not at all or Always) to 7 (\> once a day or \< one day) and Items 3-9, 11-13 are rated on 9-point scales with responses from 0 (No desire, Not important at all, or Extremely low desire) to 8 (Strong desire, Extremely important, or High desire). High scores indicated a high level of sexual desire. The scores range from 0 to 108.

    Time frame: From enrollment to the end of treatment at one week and three months

07

Study locations

1 site
  • The university of Hong Kong
    Hong Kong, 000000, Hong Kong
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06353308
Lead sponsor
The University of Hong Kong
Responsible party
Sponsor
First posted
Apr 9, 2024
Start date
May 12, 2023
Primary completion
Feb 10, 2024
Completion
Mar 2, 2024
Last update
Apr 9, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion